Clinical Trial Update: Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

View source ↗

Summary

A clinical trial update reporting on the efficacy and safety of MK-0518 (raltegravir) in treatment-experienced HIV-1 infected adults with hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hemophilia

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: HIV Infection, Hemophilia A | Status: UNKNOWN